Bank of New York Mellon
AMAM

Bank of New York Mellon’s Ambrx Biopharma, Inc. Common Stock AMAM Stock Holding History

Bank of New York Mellon’s Portfolio AMAM Stock Details AMAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-47,433
Closed -$545K – 4397
2023
Q3 		$545K Buy
+47,433
New +$545K ﹤0.01% 3495